cjc-1295 ipamorelin vial + 10mg CJC/Ipamorelin

The formulation pairs a modified GHRH(1-29) analog with a selective growth hormone secretagogue receptor (GHS-R) agonist, allowing concurrent investigation of GHRH and ghrelin / GHS pathway activation

Such method overcomes the expense and/or inconvenience of intravenous glutathione administration and also overcomes the increased likelihood of side-effects associated with the ingestion of high doses of glutathione

Why it was included in the FDA ban There have been no human trials on KPV to date

Research suggests it may help support the quality of the sleep cycle and deep sleep phases (Delta-wave sleep), which is when the body naturally secretes its largest pulse of growth hormone